Woodline Partners LP Pro Qr Therapeutics N.V. Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Woodline Partners LP holds 1,325,655 shares of PRQR stock, worth $2.23 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,325,655
Previous 3,557,001
62.73%
Holding current value
$2.23 Million
Previous $9.71 Million
81.84%
% of portfolio
0.01%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding PRQR
# of Institutions
67Shares Held
40MCall Options Held
30.1KPut Options Held
5.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$13.6 Million0.02% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.38 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.52 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$3.48 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.45 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $120M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...